Sangamo Therapeutics, Inc.
0.12USD
+0.0000 (+0.00%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SGMOQ.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Next year | -$0.03▼ | $0.02 | 2 | 1 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-03-31 | -$0.07 | -$0.08 | -0.01 (-14.3%) |
| 2025-12-31 | -$0.05 | -$0.07 | -0.03 (-54.7%) |
| 2025-09-30 | -$0.1 | -$0.11 | -0.01 (-6.5%) |
| 2025-06-30 | -$0.13 | -$0.08 | +0.04 (+36.0%) |
1 rating from 1 firm
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterated | Buy | $10 | Feb 10, 2026 |
15 filings from 13 insiders · 0 buy / 0 sell over 6m
Officers and directors of SGMOQ, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| DAVIS GREGORY DOfficer | Sell | 69.8k | $0.25 | $18k | Apr 22, 2026 |
| DUBOIS-STRINGFELLOW NATHALIEOfficer | Sell | 345.9k | $0.26 | $89k | Apr 21, 2026 |
| BEERS COURTNEYDirector | Grant | 25.0k | — | — | Jun 12, 2025 |
| SMITH KAREN LESLEY M.D. PH.D.Director | Grant | 25.0k | — | — | Jun 12, 2025 |
| HILLAN KENNETH J.Director | Grant | 25.0k | — | — | Jun 12, 2025 |
| CAREY ROBERT F.Director | Grant | 25.0k | — | — | Jun 12, 2025 |
| MEYERS JAMES ROBERTDirector | Grant | 25.0k | — | — | Jun 12, 2025 |
| HORN MARGARET ADirector | Grant | 25.0k | — | — | Jun 12, 2025 |
| MARKELS JOHNDirector | Grant | 25.0k | — | — | Jun 12, 2025 |
| PARKER H STEWARTDirector | Grant | 25.0k | — | — | Jun 12, 2025 |
| DAVIS GREGORY DOfficer | Grant | 49.7k | — | — | Feb 25, 2025 |
| DUBOIS-STRINGFELLOW NATHALIEOfficer | Grant | 120.0k | — | — | Feb 25, 2025 |
| WILLOUGHBY SCOTT BGeneral Counsel | Grant | 120.0k | — | — | Feb 25, 2025 |
| DURAIBABU PRATHYUSHAChief Financial Officer | Grant | 120.0k | — | — | Feb 25, 2025 |
| MACRAE SANDYChief Executive Officer | Grant | 375.0k | — | — | Feb 25, 2025 |
Members whose judged calls on SGMOQ have played out most reliably.
No settled calls on SGMOQ yet. 1 call is open, the first due Sep 20, 2027.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
1 analyst covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 0 | 0 | 0 | Buy2.00 |